Literature DB >> 2123092

Characterization of a Gla-containing protein from calcified human atherosclerotic plaques.

B L Gijsbers1, L J van Haarlem, B A Soute, R H Ebberink, C Vermeer.   

Abstract

In this article we describe the isolation of a 4-carboxyglutamic acid (Gla)-containing protein from calcified human atherosclerotic plaques. The protein was extracted from pulverized calcified plaques by demineralization with ethylenediaminetetraacetate and was subsequently purified by anion-exchange fast protein and high-performance liquid chromatography by using ion-exchange and gel-filtration columns. The protein was designated as plaque Gla protein (PGP) and has an apparent mass of 23 kD as estimated from sodium dodecyl sulfate-polyacrylamide gel analysis. By determining the sequence of its first six amino acid residues, the protein was unequivocally demonstrated to be not related to any other known protein. Moreover, no immunological relationship (as tested by Western blot analysis) was found between PGP and other known Gla-containing proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123092     DOI: 10.1161/01.atv.10.6.991

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  7 in total

1.  Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss.

Authors:  M H Knapen; K S Jie; K Hamulyák; C Vermeer
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

Review 2.  Coronary arterial calcification as an active process: a new perspective on an old problem.

Authors:  T M Doherty; R C Detrano
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

3.  Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis.

Authors:  L A Fitzpatrick; A Severson; W D Edwards; R T Ingram
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

4.  The level of hepatic ABCC6 expression determines the severity of calcification after cardiac injury.

Authors:  Christopher Brampton; Zouhair Aherrahrou; Li-Hsieh Chen; Ludovic Martin; Arthur A B Bergen; Theo G M F Gorgels; Jeannette Erdmann; Jeannette Erdfdi; Heribert Schunkert; Zalán Szabó; András Váradi; Olivier Le Saux
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

5.  Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis.

Authors:  H Min; S Morony; I Sarosi; C R Dunstan; C Capparelli; S Scully; G Van; S Kaufman; P J Kostenuik; D L Lacey; W J Boyle; W S Simonet
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

6.  Computational identification of 4-carboxyglutamate sites to supplement physiological studies using deep learning.

Authors:  Sheraz Naseer; Rao Faizan Ali; Suliman Mohamed Fati; Amgad Muneer
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

Review 7.  The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability?

Authors:  Fabrizio Montecucco; Sabine Steffens; François Mach
Journal:  Clin Dev Immunol       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.